CJC-1295 (DAC)

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic growth hormone-releasing hormone (GHRH) analogue designed for research purposes. The DAC modification extends the peptide's half-life, allowing for less frequent administration while maintaining sustained activity.

This compound is intended for laboratory and research applications only. It works by stimulating the pituitary gland to promote growth hormone secretion, making it a subject of interest in scientific studies exploring hormonal regulation and metabolic processes.

Supplied as a research chemical for qualified researchers and institutions. Not for human consumption or veterinary use.